Product
Forxiga
Aliases
Dapagliflozin, Forxiga 10mg
4 clinical trials
3 indications
Indication
Diabetes MellitusIndication
HealthyIndication
Type 1Clinical trial
A Multicenter, Double-blind, Active-controlled, Randomized, Parallel, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablet Produced by PT Dexa Medica in Comparison With the Comparator Drug (Forxiga® 10 mg Film-Coated Tablet, Manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China Imported by PT AstraZeneca Indonesia, Indonesia)Status: Completed, Estimated PCD: 2023-03-15
Clinical trial
SGLT-2 Inhibition Using Dapagliflozin During and After Physical Exercise - Effects on Glycemic Variability, Hormonal Regulators of Glucose Homeostasis and Ketone Body in Type 1 Diabetes - a Randomized, Placebo-controlled, Open-label, Cross-over Intervention StudyStatus: Completed, Estimated PCD: 2023-04-26
Clinical trial
Effects of SGLT-2 Inhibitor Dapagliflozin on Hormonal Glucose Regulation and Ketogenesis in Patients With Type 1 Diabetes - a Randomised, Placebo-controlled, Open-label, Cross-over Intervention StudyStatus: Completed, Estimated PCD: 2020-11-12